Permite
Clinical indication(s) / Claim(s)
Verbatim per manufacturer's Instructions-for-use (IFU) sheet

IFU Link
Claim 1: Filling material as a treatment for dental caries



Clinical evidence supporting the claim(s)
From full report(s) of prospective, clinical controlled trial(s)
Clinical evidence not supporting the claim(s)
From full report(s) of prospective, clinical controlled trial(s)
Clinical evidence not related to the claim(s)
From full report(s) of prospective, clinical controlled trial(s)
(c) RCHSR
CQ-Score of the publication
Criterion I = 1 Criterion II  = 0 Criterion III  = 0 / Total score = 0
CQ-Score of the publication
Criterion I = 1 Criterion II  = 0 Criterion III  = 0 / Total score = 0
CQ-Score of the publication
Criterion I = 0 Criterion II  = 0 Criterion III  = 0 / Total score = 0
Claim 1:
de Miranda L. Estudo clínico randomizado e controlado comparando o tratamento restaurador atraumático ao convencional com amálgama em molares decíduos: avaliação após 6 e 12 meses. Thesis; 2005.

Hilgert LA, de Amorim RG, Leal SC, Mulder J, Creugers NH, Frencken JE. Is high-viscosity glass-ionomer-cement a successor to amalgam for treating primary molars? Dent Mater. 2014 Oct;30(10):1172-8.

Mijan M, de Amorim RG, Leal SC, Mulder J, Oliveira L, Creugers NHJ, Frencken JE. The 3.5-year survival rates of primary molars treated according to three treatment protocols: a controlled clinical trial. Clin Oral Investig. 2014 May;18(4):1061-1069.